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Lipid A structure at the air–aqueous interface has been studied using pressure-area isotherm methods coupled with the surface X-ray scattering
techniques of X-ray reflectivity (XR) and grazing incidence X-ray diffraction (GIXD). Lipid A monolayers were formed at the air–aqueous
interface to represent the lipid moiety of the outer membrane of Gram-negative bacteria. Lipid A structure was characterized at surface pressures
between 10 and 35 mN/m. Interactions of α-helical antimicrobial peptides LL-37, SMAP-29 and D2A22 with lipid A monolayers were
subsequently studied. Although insertion into the lipid A monolayers was observed with the α-helical peptides, little change was seen from the X-
ray data, suggesting that the lipid A hydrocarbon chains are involved in reorientation during insertion and that the hydrocarbon chains have a
relatively rigid structure.
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Microbial disease is on the increase worldwide [1–3] and
because of this the development of novel antimicrobial
pharmaceutical agents is of the utmost importance. In order
for the design and development of new antibiotic drugs to
progress, it is essential to understand how antimicrobial
peptides kill bacteria.
The cell wall of Gram-negative bacteria is composed of two
membranes, the outer membrane being composed of a
phospholipid layer on the inner leaflet and a glycolipid layer
on the outer leaflet. The glycolipid layer is composed of
lipopolysaccharides (LPS) [4,5] and is anchored in place by the
lipophilic moiety of the LPS known as lipid A [6,7]. Since lipid
A is an important component of the outer membrane of Gram-
negative bacteria, it is a prospective target for the design of
novel antibacterial drug compounds. To this end, it is of interest⁎ Corresponding author. Tel.: +1 312 567 3534; fax: +1 312 567 8874.
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doi:10.1016/j.bbamem.2006.01.025to study its properties and the interactions between lipid A and
other molecules.
The structure of lipid A can vary slightly depending on the
bacterial species from which it is isolated [4]. Nevertheless,
there has been a substantial body of work on the determination
of the structure of lipid A isolated from E. coli [6,8–11]. It has
been determined that lipid A (from E. coli) is a glucosamine
disaccharide with β (1→6) linkage to two phosphate groups
which are attached at positions 1 and 4′ [8,9]. Lipid A is also
acylated, with up to seven acyl chains either amide- or ester-
linked to the diglucosamine backbone [11]. The work carried
out for this paper used a lipid A prepared from a rough strain
(F583) of E. coli lipopolysaccharide. The naturally occurring
cytotoxic diphosphoryl form of lipid A was used (Fig. 1).
Lipid A has previously been studied to observe its structural
properties by using a range of techniques. Takayama et al. [7]
combined mass spectrometry and NMR to study an early
precursor in the biosynthesis of lipid A and postulated the
structure of lipid A in E. coli. Imoto et al. [8] also used NMR to
study the structure of the lipid A component of E. coli
lipopolysaccharide and they later confirmed their results using
Fig. 1. Structure of lipid A molecule isolated from E. coli, with six hydrocarbon
chains.
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Brandenburg et al. [11,13] used Fourier transform infrared
(FTIR) spectroscopy to show that the tilt of different forms of
lipid A varies with endotoxicity and that the comparison of a
partial lipid A structure with a natural hexa-acyl lipid can be
used to determine the biologically active unit of lipid A.
Lipid A is an essential part of the lipopolysaccharide and as such it
canbeused to study interactionsof antimicrobialdrugcompoundswith
Gram-negative bacterial surfaces. One such type of antimicrobial
agents which may be studied are antimicrobial peptides [14,15].
Antimicrobial peptides are of increasing interest for their potential as
future pharmaceutical drugs since thesepeptides target the lipid regions
of cell membranes and cause membrane disruption and cell death
[15,16]. Antimicrobial peptides may be isolated from a variety of
organisms and they are also being syntheticallymade. All the peptides
used in this studycomefromtheCathelicidin familyofpeptides.LL-37
(LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES) is the
only human Cathelicidin antimicrobial peptide, SMAP-29
(RGLRRLGRKIAHGVKKYGPTVLRIIRIAG) is of ovine origin
[17] and D2A22 (FARKFLKRFKKFVRKFIRFAFLF) is a designed
synthetic analogue of a Cathelicidin peptide and it has bactericidal
action against S. aureus and P. aeruginosa [18].
One of the most important stages of peptide–membrane
interaction is the initial contact of the peptide with the outer
leaflet of the membrane. In order to investigate how peptides
interact with specific membrane lipids, methods that allow the
membrane to be modeled in a fluid environment are needed.
This may be carried out by the use of a Langmuir monolayer to
mimic the external leaflet of the cell membrane, coupled with
the introduction of peptides into the subphase of a Langmuir
trough to represent the extracellular fluid and thus the approach
of the peptide towards the cell surface. Langmuir monolayers of
different lipids can be used to represent the membrane of
different cell types and changes in membrane structure resulting
from its interaction with peptides.
Lipid A structure and its interactions with other molecules
was initially studied decades ago [6,7,9,10,19–21]. In recent
years, research on lipid A structure at the air–aqueous interfaceand the interactions of lipid A with other molecules have
become more prevalent [22–25]. Investigations of lipid A at the
air–liquid interface utilizing Langmuir monolayers of lipid A
molecules have been recently published [22,23,25]. It has been
shown that both mono- and di-phosphoryl lipid A can form
stable monolayers at the air–liquid interface which on
compression show transitions from a liquid-expanded state to
a more condensed one [22,23,25].
Some of this research focuses on interactions of lipid A films
with antimicrobial peptides [22,25,26] and has observed these
interactions with the use of the Langmuir trough technique
coupled to other methods such as atomic force microscopy
(AFM) [25], epifluorescence [26] and X-ray scattering [22]. The
antimicrobial peptides studied with the lipid A systems include
polymyxin B [25], protegrin-1 [22] and LL-37 [26]. The latter
two publications presented for the first time compression and
insertion isotherm data which showed phase transitions of lipid
A at the aqueous surface and the changes in lipid A monolayer
upon injection of peptides into the Langmuir trough subphase.
In this paper, a more detailed structural characterization of
lipid A layers using surface X-ray scattering techniques is
presented and structural studies of their interactions with
antimicrobial peptides are attempted for the first time using
grazing incidence X-ray diffraction and X-ray reflectivity
techniques. Furthermore, these techniques are combined with
insertion assays to observe the interaction of three different a-
helical antimicrobial peptides.2. Materials and methods
2.1. Lipid A monolayers
Lipid A is a major component of lipopolysaccharides from the outer layer
of Gram-negative bacterial cell walls. Lipid A ([diphosphoryl, from E. coli
F583], was purchased from Sigma-Aldrich and used without further
purification. Lipid A was spread from a 74:23:3 v/v% chloroform:
methanol:water solution.
2.2. Peptides
The peptides used in this study were synthetically made LL-37, SMAP-
29 and D2A22. LL-37, SMAP-29 and D2A22 (90–95% purity) were
purchased from Pepceuticals Ltd. A working solution of 10 μg/ml LL-37,
SMAP-29 or D2A22 in 0.01% w/v acetic acid was injected under the
subphase surface to give a final concentration in the subphase of 0.04 μg/ml
or 0.1 μg/ml. All experiments were carried out with a subphase temperature
of 22 °C±1 °C.
2.3. Pressure-area compression isotherms and pretreatment
experiments
Insertion experiment data presented here were obtained using a custom-built
trough [22,27] at the University of Chicago. All experiments were performed on
Dulbecco's Phosphate Buffered Saline (DPBS) (Invitrogen Life Technologies)
without calcium and magnesium ions. Pressure-area compression isotherms
were carried out as follows. Upon spreading, the lipid A film was left
undisturbed for 15 min to allow for solvent evaporation. At this point, barrier
compression was initiated and the increase in surface pressure of the monolayer
was monitored with decrease in area.
Pretreatment experiments were carried out to observe the extent of
peptide self-assembly at the air–liquid interface when lipid A was present in
Fig. 2. Pure lipid A and pretreatment compression isotherms. LL-37 isotherm
has been presented at a scale of one third of its real area per molecule, with the
pressure values being those actually recorded. Area per molecule refers to area
per lipid molecule.
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incorporated in the lipid A layer at higher pressures if the peptide adsorbed at
low pressure. A typical experiment consisted of lipid A being spread on the
surface, the system being left to equilibrate (15 min) and subsequent peptide
injection into the system under the lipid A monolayer using a microsyringe
with a L-shaped needle (VDRL needle; Hamilton, Reno, NV). The data
presented in this paper show pretreatment data for LL-37 and SMAP-29.
After injection of peptide, the system was left for a further fifteen min in
order to allow for any pressure changes due to injection of peptide to the
system. The system was then compressed at a rate of 2 cm2/min as for a
normal pressure-area isotherm and the data compared with those of pure lipid
A. Since the insertion assays involve compression of the lipid before peptide
injection, these types of experiments have been termed “pretreatment” since
the lipid layer is “pretreated” with the peptide before compression.
2.4. Insertion isotherms
Insertion experiments were carried out to quantify the interaction of
antimicrobial peptides with the lipid A monolayer. Initially, the lipid A monolayer
was deposited and equilibrated, followed by compression to the required surface
pressure (ranging from 20 mN/m to 40 mN/m). This range of surface pressure was
used as it corresponds to the liquid-condensed phase of lipids determined from
repeated isotherms and the data would be able to be directly compared with data at
the same pressures using different lipids [28]. Insertion isotherms were carried out
in the constant pressure mode where the surface pressure was kept constant via a
built-in controlled feedback system by adjusting the surface area. The peptide
solution was then uniformly injected underneath the monolayer as in the
pretreatment experiments. The injection of peptides under the compressed lipid
monolayer mimics the approach by the peptide to the outer surface of the cell, as the
hydrophilic head groups would be closest to the subphase, simulating the outer part
of the membrane, and the peptide in the subphase would mimic the peptide in the
extracellular fluid. The resulting relative change in area per molecule, ΔA/A, was
monitored throughout the experiment to compare the degree of peptide insertion
into lipid A monolayers.
2.5. Grazing Incidence X-ray Diffraction (GIXD) and X-ray
Reflectivity (XR)
X-ray scattering measurements were taken at the European Synchrotron
Radiation Facility (ESRF), using a custom built Langmuir trough equipped with
a single moveable barrier as described previously [22,28,29].
Grazing incidence X-ray diffraction (GIXD) [30] is used to obtain in-
plane information concerning the molecular structure of surfaces [31]. For the
GIXD measurements, the angle of incidence (αi) was set to strike the air–
aqueous interface at an incident angle of 0.8 αc, where αc is the critical angle
for total external reflection. When the incident angle is less than the critical
angle the phenomenon of total external reflection occurs and the refracted
wave becomes an evanescent wave whose intensity decreases exponentially
with depth and travels parallel to the interface below the surface. Typical
penetration depth at 0.8 αc is 76 Å. If the surface film contains order of a
sufficiently long range, the evanescent wave will be diffracted by the ordered
structure of the monolayer. This makes this method very surface sensitive.
The intensity profile as a function of scattering angle was recorded by a
linear position sensitive detector (PSD) that detected the diffracted beam. The
incident wavelength used was 1.5 Å.
Grazing incidence X-ray diffraction measurements are made with variation of
the X-ray momentum transfer component qxy that is parallel to the air–aqueous
interface. The reflections of the Bragg peaks observed with this geometry can be
indexed by two Miller indices, hk. Their angular positions 2θhk, corresponding to
qhk=(4π/λ) sin θhk, yield the repeat distances dhk=2π/qhk=2π/qxy for the two-
dimensional (2D) lattice structure [32,33]. Bragg peak profiles (intensity against qxy)
were fitted with Gaussians and the peak position values were used to obtain unit cell
dimensions of the lipid lattices. The observation of two Bragg peaks in the
diffraction pattern of an amphiphilic monolayer is indicative of a distorted
hexagonal (which can be viewed as centered rectangular) unit cell. Therefore, all
unit cell dimensions in this paper have been calculated using the centered
rectangular unit cell approximation.Specular X-ray reflection measurements yield the gradient of electron
density distribution perpendicular to the interface and may be used to model the
film composition [30,32,34].
When specular X-ray reflection occurs, the scattering vector qz (perpendicular to
the surface) may be calculated from qz=4π sin α/λ, where α is the grazing angle of
the incident beam and λ the wavelength of the X-ray beam. When the reflectivity is
measured as a function of the scattering vector qz, the reflectivity curve contains
information regarding the gradient of the electron density profile in the direction
normal to the surface [33,35]. X-ray reflectivity measurements were carried out at a
range of angles corresponding to qz values of approximately 0 to 0.6 Å
−1. The
reflected beam intensitywasmeasured as a function of the incident angle using aPSD
for simultaneous detection of specular reflection and diffuse scattering.
This provided an electron density profile averaged laterally across the
footprint of the X-ray beam and was modeled by the deviation of the measured
specular X-ray reflectivity from Fresnel's law for a perfect interface. The
interface is modeled as a stack of slabs, where each slab has a constant electron
density, thickness and interfacial roughness. The model was then least square
fitted to the experimental data.
3. Results and discussion
3.1. Compression and pretreatment isotherms
The lipid A pressure-area isotherm (Fig. 2) has been
measured all the way through until the monolayer collapsed at
60 mN/m. However, it is interesting to note that the area per
molecule at 30 mN/m is approximately 127 Å2/molecule. This
is of interest for two main reasons. Firstly, the pressure
corresponding to a lipid state in a natural membrane ranges
from 25 to 40 mN/m [36–38] and thus it can be supposed that
this is the approximate area per molecule lipid A would take
within the membrane. Secondly, when comparing this value
with other published work it can be seen that this value agrees
with other published data [22,23,39] where the approximate
area per molecule of lipid A is around 125–130 Å2 in all three
cases.
Although the lipid A molecule has an unusually complex
structure for a membrane lipid (Fig. 1), its isotherm shows that
the lipid A monolayer undergoes phase transitions on
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compression pressure-area isotherm is qualitatively similar to
others obtained previously [11,23,25]. However, the surface
pressure value of the plateau region in the pressure-area
isotherm (Fig. 2) is more comparable to the isotherm produced
by Retzinger et al. [23] than to Brandenburg et al. [11] and the
area per molecule values at the phase transition points are
similar.
Pretreatment experiment data (Fig. 2) show there was an initial
increase in pressure of approximately 8mN/mwhen the LL-37was
injected under the lipidA film at∼0mN/m, but therewasmuch less
increase with the SMAP-29 system. On compression, the lipid A
liquid-extended/liquid-condensed phase transition is still visible in
the both pretreated systems. However, it is shifted to the larger
molecular area values by around 70 Å2/molecule units from the
value seen in the pure lipid A isotherm for the LL-37 system and
∼30 Å2/molecule units for the lipid Awith SMAP-29 system. The
phase transition observed in the LL-37 isotherm is also visible in the
lipid A with LL-37 system pretreatment compression curve,
suggesting the presence of LL-37 at the surface as well as the
lipid A. The onset of collapse of the lipid A with LL-37 system
begins at a much larger value of area per molecule than for the pure
lipidAmonolayer and it could be speculated that the LL-37 binds to
lipid A to form a complex at the air–liquid interface as has been
suggested for the DPPG with LL-37 system [28]. The lipid Awith
SMAP-29 system shows similar tendencies to theLL-37 systembut
to a lesser extent. The pretreatment isotherms strongly suggest that
the lipid A at the surface has some role in the attraction of
antimicrobial peptides to Gram-negative bacterial surfaces.
3.2. Insertion isotherms
Insertion assay data for lipid A experiments using two
concentrations of LL-37 (0.04 μg/ml and 0.1 μg/ml) at constant
pressures of 30 mN/m and 40 mN/m (Fig. 3) show varying
results depending on the concentration and pressure used. The
systems with lower concentration of LL-37 show increases in
area of around 32% at both 30 mN/m and 40 mN/m. However, aFig. 3. Insertion isotherms of lipid A showing percentage change in area per
molecule after injection of LL-37 at 30 mN/m and 40 mN/m constant pressure.very large increase in area (∼166%), is seen on the injection of
0.1 μg/ml LL-37 under the lipid A monolayer at 30 mN/m,
whereas there is less insertion at the higher pressure. This is
very similar to the DPPG systems which show a 180% increase
in area at the same conditions of LL-37 insertion [26,28]. The
data suggest that because the lipid A is more closely packed at
the higher pressure of 40 mN/m, less insertion can occur, unlike
DPPG with LL-37 at 40 mN/m [28] or lipid Awith protegrin-1
at 35 mN/m [22], where critical destabilization, followed by
monolayer collapse takes place.
Insertion assays using SMAP-29 and D2A22 peptides at
30 mN/m and 40 mN/m (Fig. 4) show that the D2A22 and
SMAP-29 peptides insert into the lipid A monolayer to a
similar extent at 30 mN/m with an increase in area of around
40%. At the higher pressure of 40 mN/m, the SMAP-29
peptide inserts into the lipid A monolayer to a greater extent
than the D2A22 peptide. This result may be attributed to
differences in amino acid composition of these peptides.
SMAP-29 has a higher overall net positive charge than
D2A22 which could facilitate insertion. The high proportion
of phenylalanine residues in D2A22 may contribute to the
lower insertion seen at 40 mN/m, since the large proportion
of bulky ring structures may inhibit penetration into the
monolayer which is not the case with SMAP-29 as it only
has one ring containing amino acid.
3.3. GIXD–Lipid A monolayers
Grazing incidence X-ray diffraction provides information on
the in-plane structure of the lipid monolayer being studied.
Lipid A has a much more complex structure (Fig. 1) than other
membrane phospholipids such as phosphatidylcholine and
phosphatidylglycerol lipids which only contain two hydrocar-
bon chains. Lipid A not only has a more complicated “head”
group structure, but the tail groups, are more complex in
structure. They can number up to seven per molecule due to the
fact that the lipid is extracted from bacteria and therefore can
contain lipid molecules which have not been fully synthesized
in vivo. GIXD can be used in combination with pressure-area
isotherms to determine the average structure of the lipid A
molecules produced from the F583 strain of E. coli.
GIXD data (Fig. 5) of lipid A at 30 mN/m show two Bragg
peaks with d-spacings of 4.33 Å and 4.19 Å, which correspond
to centered rectangular unit cell dimensions of a=5.06 Å and
b=8.38 Å and thus area per hydrocarbon chain of 21.2 Å2. It is
thought that the approximate area per molecule of lipid A at
30 mN/m is 120–130 Å2 (Fig. 2) [11,22,23] thus demonstrating
that there are on average six hydrocarbon chains per molecule.
Therefore from the unit cell dimensions the area per molecule at
30 mN/m, the area per lipid A molecule is 127.2 Å2. It is
necessary to mention that due to the fact that the lipid is
extracted from bacteria it contains a range of slightly different
lipid A molecules (with varying numbers of hydrocarbon
chains) and thus the exact molecular mass of lipid A cannot be
determined and so the area per molecule has to be approximated
to an average. Here, we have used a molecular mass of 1700 for
lipid A as supplied by the manufacturer.
Fig. 5. Bragg peak plot of scattering vector qxy as a function of intensity
integrated over qz<1.1 Å
− 1—constant pressure experiments of injection of LL-
37 or SMAP-29 under lipid A monolayer at 30 mN/m. The initial Bragg peaks
from scattering of ordered structure of the lipid A monolayer are left practically
unchanged on injection of LL-37 or SMAP-29 [41]. For clarity, the data have
been offset vertically.
Fig. 4. Insertion isotherms of lipid A showing percentage change in area per
molecule after injection of 0.1 μg/ml SMAP-29 and D2A22 at 30 and 40 mN/m
[41].
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compared with the GIXD data of lipid A monolayers at 20 and
35 mN/m (data not shown). d-spacing values for the lipid A
monolayer at 20 mN/m were determined as 4.37 Å and 4.15 Å,
which translates to unit cell dimensions of a=5.14 Å and
b=8.30 Å, which gives an area per unit cell of 42.7 Å2 and an
area per six hydrocarbon chain lipid A molecule of 128.1 Å2. As
expected, this value is slightly larger than that at 30 mN/m since
the lipid A monolayer is less compressed than at 30 mN/m. The
data of the lipid Amonolayer at 35 mN/m gave d-spacing values
of 4.31 Å and 4.17 Å, unit cell dimensions of a=5.03 Å and b
8.33 Å, with an area per lipid A molecule of 125.7 Å2, assuming
a lipid A molecule with an averaged number of hydrocarbon
chains of six. This is smaller than at 20 and 30 mN/m as
expected, due to further compression of the lipid A monolayer.
3.4. GIXD–Lipid A/peptide interactions
GIXD data of the lipid A monolayer at 30 mN/m after the
injection of 0.04 μg/ml LL-37 as well as after injection of
0.1 μg/ml LL-37 [41] and SMAP-29 are shown in Fig. 5.
GIXD results suggest that there is little apparent change to the
tail order on addition of LL-37 or SMAP-29 to the system.
However, the slight decrease in intensity suggests some
peptide insertion, reducing the number of scattering centers
from the ordered lipid A tail structure and thus the scattering
intensity. For the lipid A with 0.04 μg/ml LL-37 system, the
d-spacing values were 4.3 Å and 4.19 Å. This computes to
unit cell dimensions of a=5.06 Å, b=8.38 Å and an area per
molecule of A=127.2 Å2 assuming a lipid A molecule with
six hydrocarbon chains. The data for the higher concentration
of LL-37 give d-spacing values of 4.32 Å and 4.19 Å, and
unit cell dimensions of a=5.05 Å and b=8.39 Å, giving an
area per molecule value of 127.2 Å2 which is the same value
as the lipid A monolayer alone and with the injection of the
lower concentration of LL-37.
As can be seen from Fig. 5, the injection of SMAP-29
under the lipid A monolayer at 30 mN/m also gave verysimilar results to that of the pure lipid A monolayer. d-spacing
values were 4.32 Å and 4.19 Å which gives unit cell
dimensions of a=5.05 Å and b=8.38 Å and an area per
molecule value of 126.9 Å2 assuming a six chain lipid A
molecule. The GIXD results of the lipid A after LL-37 and
SMAP-29 insertion (Fig. 5) show that there was little apparent
change to the lipid packing when the peptide was injected into
the subphase. However, it is known that the peptide inserts
into the lipid A monolayer due to a change in area per
molecule during a constant pressure experiment (Figs. 3 and
4). This is thought to be due to the complex structure of the
lipid A tail groups which cannot change greatly with regard to
d-spacing due to their packing and thus can only change due to
rotation of the molecules where the hydrocarbon chains remain
with the same d-spacings. Also, the range in number of
possible hydrocarbon chains may also have an effect on these
lipid–peptide interactions.
3.5. XR–Lipid A characterization
Lipid A films were studied over a range of surface pressures
which are relevant to physiological conditions [37,38] and X-
ray reflectivity was used to structurally characterize lipid A
monolayers at the air–aqueous interface.
The lipid A reflectivity data (Fig. 6) were modeled as two
slabs, one representing the hydrophobic hydrocarbon chains,
and the other the hydrophilic head region which contains the
diphosphorylated sugar groups.
X-ray reflectivity data analysis of the lipid A system at
10 mN/m yielded a tail group slab thickness of 10.9 Å with
an electron density normalized to the substrate (0.337 eÅ−3)
Fig. 7. Reflectivity data and corresponding fits of lipid A monolayer at 30 mN/m
with injection of LL-37. The modeled fitting data show that there is a slight
increase in lipid A layer thickness after addition of LL-37 due to insertion into
the head group regions localized on the subphase side of the lipid A monolayer.
For clarity, the data have been offset vertically.
Fig. 6. X-ray reflectivity data and corresponding fits normalized by Fresnel
reflectivity plotted against scattering vector (qz) of lipid A monolayers at
different pressures. The data show that the lipid A monolayer thickens on
compression. For clarity, the data have been offset vertically.
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3.7 Å, with a normalized electron density of 1.57. The
thickness of the tail group and its electron density can be
attributed to the fact that the lipid A film is not tightly packed
at this pressure (Fig. 2), and thus the tails of the lipid A
molecules are not fully aligned or in an ordered structure.
This is corroborated by the lack of Bragg peaks from the lipid
A monolayer at 10 mN/m (data not shown). The electron
density values may be calculated using the layer thickness
and area per molecule at 10 mN/m (180 Å2) to obtain the
volume, when the number of electrons is known (assuming a
hexa-acyl lipid A molecule). The calculated normalized
electron density values are 0.95 and 1.57 for the tail and
head groups, respectively, which show that the fitted values
are in good agreements with the theoretically calculated ones.
The thickness of the head group seems small at this pressure.
However, it is suggested that this is because at this pressure
the head group is aligned parallel to the air–aqueous surface
due to the larger amount of space available to the lipid A
molecules at this pressure. Upon compression the lipid A
molecules reorient themselves, so that their hydrocarbon tails
tilt and align to form an ordered structure. This is
demonstrated in a schematic cartoon of the lipid A films at
increasing pressures (Fig. 8A) which shows the rearrangement
of the lipid A molecules on compression.
XR data analysis of lipid A monolayer at 20 mN/m
showed that the tail group thickens on compression and the
electron density of both the head and tail group increases. At
20 mN/m, the best fit yielded a lipid A tail group thickness of
13.3 Å with a normalized electron density of 0.99 and a head
group thickness of 5.1 with an electron density of 1.65. At
20 mN/m, the lipid A has been compressed to the liquid-
condensed phase (Fig. 2). The noticeable change in electron
density and thickening of the tail group slab may be
attributable to the alignment of the lipid A molecules into
an ordered structure representing the liquid-condensed phase
of the lipid monolayer.3.6. XR–lipid A–host-defence peptide interactions
XR data for pure lipid A monolayer may be a good reference
point for further experiments which involve peptide/lipid
interaction. Any difference between the pure lipid A data and
the data taken after peptide injection may be attributed solely to
the effect of peptides on the interface structure.
XR data for lipid A with LL-37 system look very similar to
the pure lipid A data, although there are subtle changes in terms
of electron density and layer thickness (Fig. 7). The layer
thickness values returned for lipid A with 0.04 μg/ml LL-37
system are 13.9 Å and 6.9 Å for the tail and head groups,
respectively, which are reasonably similar to the values for the
pure lipid A monolayer. Comparison of normalized electron
density values for the tail and head group layers (0.92 and 1.44,
respectively) to those of the pure lipid A monolayer at the same
pressure, yields a decrease of up to 20% in normalized electron
density after addition of LL-37. The electron density of LL-37 is
approximately 0.381 e−/Å3 [28], and the normalized electron
density of pure lipid A head group varies from 1.57 to 1.75.
Therefore, the decreased electron density value of the lipid A
film after LL-37 injection could be attributed to the fact that the
LL-37 inserts mainly into the head region of the lipid A
monolayer. Thus, the head group normalized electron density
decreases from 1.75 to 1.44 whilst at the same time overall
interfacial layer thickness increases because the peptides do not
insert completely into the monolayer and some residues remain
‘sticking out’ into the subphase. The decrease in tail electron
density can be explained accordingly. LL-37, inserting between
lipid A head groups pushes apart the otherwise rigid lipid A
molecules and thus the hydrocarbon chains of the lipid A
molecules remain with the same number of electrons but occupy
a greater area.
When the higher concentration of LL-37 peptide was used, a
further change in the layer composition has been observed. The
tail layer decreased in thickness to a value of 12.4 Å, with a
Fig. 8. Cartoon schematic of characterization of lipid A films at the air–aqueous
interface and the possible interactions of LL-37 with lipid A monolayers.
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increased in thickness to a value of 8.5 Å, whilst decreasing in
density to 1.32. This suggests that as more LL-37 is injected into
the subphase, more peptides insert into the monolayer, which is
corroborated by the insertion isotherms (Fig. 3).
A cartoon schematic of the interactions of LL-37 with lipid A
monolayers is proposed (Fig. 8B). As has been previously
discussed, it is thought that the tail structure of the lipid A
molecules is fairly rigid and therefore it is more likely that the
peptide will insert mostly into the head region of the lipid.
When the concentration was increased from 0.04 μg/ml to
0.1 μg/ml, more peptide molecules inserted into the lipid A
monolayer, exerting some pressure on the lipid molecules. This
is corroborated by the fact that little change in the GIXD
spectrum was observed upon peptide injection, but the XR data
differ significantly indicating the increasing head group layer
thickness and decrease in its electron density (Fig. 8B).
4. Summary and conclusions
The lipid component of the outer leaflet of the outer
membrane of Gram-negative bacteria such as Escherichia,
Salmonella and Chlamydia is composed a lipid known as lipidA. It is this lipid A component that is most likely to be targeted
by antimicrobial peptides. The Langmuir monolayer approach
to modeling peptide- or protein–membrane interactions proved
to provide information inaccessible by other methods. However,
to date no structural study of lipid A Langmuir films has been
performed using GIXD and XR. This paper provides a detailed
structural investigation of lipid A monolayers as well as lipid A
films interaction with three different antimicrobial peptides.
The results of this study show how lipid A monolayers may
be characterized using Langmuir trough techniques coupled to
the X-ray scattering techniques of grazing incidence X-ray
diffraction and X-ray reflectivity. This study also shows for the
first time how the α-helical peptides LL-37, SMAP-29 and
D2A22 can bind and insert to lipid A monolayers. The results
presented in this paper may be combined with those previously
published [26,28] and concurrent work [40] to provide a fuller
picture on the peptide–lipid interactions of these systems.
The pretreatment experiments indicated that LL-37 and
SMAP-29 α-helical peptides are likely to bind to lipid A and
form some kind of lipid–peptide complex as was observed
previously with DPPG monolayers [28]. This complex is then
compressed until collapse, demonstrating that there is some
permanent binding between lipid A and the peptide.
Insertion assays showed similar trends for the all the α-
helical peptides used. In general, the greatest increase in
molecular area upon peptide injection was displayed with the
higher concentration of α-helical peptide at (0.1 μg/ml) and the
lower pressure of 30 mN/m. Concurrent work [40] shows that a
β-sheet peptide (Protegrin-1) shows similar insertion profiles to
its truncated version, PC-17 which shows that peptides align
themselves the same way round for insertion and that the
arginine and glycine residues at the amine and carboxyl termini
of the PG-1 peptide are not essential for peptide–lipid binding.
Analysis of the GIXD data indicates that the lipid A
monolayer has an ordered structure. Although the insertion
assays show an increase in area per lipid molecule when α-
helical peptides are injected underneath the lipid A monolayer,
GIXD data analysis shows little change in the unit cell
dimensions of the systems before and after insertion. One
possible explanation for this could be that at the pressure of
30 mN/m, the lipid A molecules are packed so tightly, that they
cannot be altered significantly even in the presence of injected
peptide and so the insertion occurs by rotation of lipid A
molecules. This results in the same d-spacings being observed
and so no apparent difference is seen when the data are
compared before and after injection. The constant pressure
mode allows the simulation of the outer leaflet of a membrane
bilayer as the area can change, but the pressure must be
maintained to keep the packed structure of the system. This
demonstrates the elasticity of the membrane which may move in
order to keep the pressure of the cell and avoid cell disruption,
although the pressure is limited to a certain value which in real
life could be exceeded in extreme circumstances.
The lipid A X-ray reflectivity data show the differences in
the monolayer structure at different surface pressures. It is clear
that monolayer packing at 10 mN/m is somewhat different than
the rest of the data. This is due to the fact that there is a phase
239F. Neville et al. / Biochimica et Biophysica Acta 1758 (2006) 232–240transition at ∼18 mN/m and below this value the lipid A
monolayer appears to be in the liquid-expanded phase, rather
than the liquid-condensed phase which is present after this co-
existence phase transition. The XR data also show that the lipid
A monolayer increases in thickness on compression which has
been observed with other lipid monolayers [29]. Monolayer
thickness values produced by other research groups are
consistent with those presented here [23,25].
Analysis of the X-ray reflectivity data for the lipid A
system after LL-37 peptide injection suggest that an increase
in the peptide concentration in the subphase leads to a
thickening of the lipid head group region. It is thought that
this happens due to the partial insertion of LL-37 into the lipid
A monolayer, with some adsorption to the head groups of the
lipid A molecules. The tail group region of the lipid A
monolayer is fairly rigid and thus the peptides insert mainly
into the head group region. However, it is likely that some LL-
37 molecules insert at least partially into the tail group
regions, which is corroborated by increase in their electron
density.
In summary, this paper presents for the first time a detailed
study of lipid A monolayers at the molecular level using surface
X-ray scattering techniques. It also shows that Langmuir
monolayers of lipid A molecules can be used to model the
outer leaflet of the outer membrane of Gram-negative bacteria in
a fluid environment where the injection of peptides into the
subphase represents the approach of the peptides to the bacterial
cell surface. The results show that lipid A has an ordered
structure at the air–liquid interface at biological relevant
pressures and that antimicrobial peptides interact with lipid A
monolayers to different extent depending on the peptide type
and structure. An understanding of how different antimicrobial
peptides interact with bacterial membrane components is
essential for the production of future pharmaceutical therapeutic
agents in the ongoing battle against antibiotic-resistant bacterial
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